Camille Zakka is the Head of Business Development at HAYA Therapeutics, a biotech company focused on precision medicines for cancer. She leverages her Ph. D. in Neuroscience from the University of Lausanne to lead the companys strategic partnering, licensing, and fundraising activities. People who have worked with her describe her as driven, curious, and insightful.
Her motivation to combat cancer is deeply personal, stemming from her familys long history with the disease. This personal connection fuels her professional work and her involvement in fundraising initiatives for organizations like The Leukemia & Lymphoma Society, demonstrating a profound commitment to making a difference in the field.
Unique fact: HAYA Therapeutics, where she is a key leader, spun out of the Lausanne University Hospital (CHUV), an institution she was already interested in.